The internet is full of false claims. Columnist Sam Kirton shares why fact-checking is important, particularly for the rare disease world.
Broadway performers will sing show tunes at a fundraising event aimed at boosting awareness of pulmonary fibrosis.
Inhibiting the HIF2 protein was found to promote repair processes in a mouse model of lung injury, and may be a strategy for ...
As columnist Charlene Marshall looks ahead to 2025, she shares some of her New Year's wishes for fellow pulmonary fibrosis patients.
Rapidly spreading wildfires have taken over the news headlines from the Los Angeles area, as I write this column. Dry weather and the Santa Ana winds joined forces to create an inferno there.
Do you make resolutions for the new year? A revealing joke on the subject has been around for years. In it, an entrepreneur opens and stocks a gym on New Year’s Day to support those who’ve made ...
Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.
The investigational therapy LYT-100 (deupirfenidone) significantly slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF), outperforming the standard of care therapy Esbriet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback